Kirstin Wingler1, Harald H H W Schmidt. 1. Monash University, Department of Pharmacology, Centre for Vascular Health, Melbourne, Australien.
Abstract
BACKGROUND: Radicals have important physiological functions, for example, in immune defense and vasoprotection. However, they are also potentially dangerous waste products of cellular metabolism and they can contribute to the development of many different diseases. METHOD: Selective literature review. RESULTS: The scientific understanding of radicals has not yet led to any therapeutic application. For many years, scavenging already formed radicals with antioxidants was considered to be the most promising therapeutic approach, but clinical trials based on this principle have yielded mostly negative results. Thus, entirely new approaches are needed. The goal should be to prevent the formation of harmful radicals, or to treat radical-related damage if it has already occurred. New diagnostic tools have the potential to identify those patients that are most likely to benefit from this form of treatment, as well as to document its success. CONCLUSIONS: A new generation of cardiovascular drugs is being developed for the prevention or the mechanism-based treatment of vascular damage caused by oxidative stress. This new therapy should go hand in hand with new diagnostics, in accordance with the principle of individualized medicine.
BACKGROUND: Radicals have important physiological functions, for example, in immune defense and vasoprotection. However, they are also potentially dangerous waste products of cellular metabolism and they can contribute to the development of many different diseases. METHOD: Selective literature review. RESULTS: The scientific understanding of radicals has not yet led to any therapeutic application. For many years, scavenging already formed radicals with antioxidants was considered to be the most promising therapeutic approach, but clinical trials based on this principle have yielded mostly negative results. Thus, entirely new approaches are needed. The goal should be to prevent the formation of harmful radicals, or to treat radical-related damage if it has already occurred. New diagnostic tools have the potential to identify those patients that are most likely to benefit from this form of treatment, as well as to document its success. CONCLUSIONS: A new generation of cardiovascular drugs is being developed for the prevention or the mechanism-based treatment of vascular damage caused by oxidative stress. This new therapy should go hand in hand with new diagnostics, in accordance with the principle of individualized medicine.
Authors: Steven P Schulman; Lewis C Becker; David A Kass; Hunter C Champion; Michael L Terrin; Sandra Forman; Kavita V Ernst; Mark D Kelemen; Susan N Townsend; Anne Capriotti; Joshua M Hare; Gary Gerstenblith Journal: JAMA Date: 2006-01-04 Impact factor: 56.272
Authors: Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch Journal: Nat Rev Drug Discov Date: 2006-09 Impact factor: 84.694
Authors: Johannes-Peter Stasch; Peter M Schmidt; Pavel I Nedvetsky; Tatiana Y Nedvetskaya; Arun Kumar H S; Sabine Meurer; Martin Deile; Ashraf Taye; Andreas Knorr; Harald Lapp; Helmut Müller; Yagmur Turgay; Christiane Rothkegel; Adrian Tersteegen; Barbara Kemp-Harper; Werner Müller-Esterl; Harald H H W Schmidt Journal: J Clin Invest Date: 2006-09 Impact factor: 14.808
Authors: Mark T Gladwin; Alan N Schechter; Daniel B Kim-Shapiro; Rakesh P Patel; Neil Hogg; Sruti Shiva; Richard O Cannon; Malte Kelm; David A Wink; Michael Graham Espey; Edward H Oldfield; Ryszard M Pluta; Bruce A Freeman; Jack R Lancaster; Martin Feelisch; Jon O Lundberg Journal: Nat Chem Biol Date: 2005-11 Impact factor: 15.040
Authors: Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud Journal: JAMA Date: 2007-02-28 Impact factor: 56.272
Authors: Zachary T Schafer; Alexandra R Grassian; Loling Song; Zhenyang Jiang; Zachary Gerhart-Hines; Hanna Y Irie; Sizhen Gao; Pere Puigserver; Joan S Brugge Journal: Nature Date: 2009-08-19 Impact factor: 49.962
Authors: S Frantz; A Adamek; D Fraccarollo; J Tillmanns; J D Widder; C Dienesch; A Schäfer; A Podolskaya; M Held; H Ruetten; G Ertl; J Bauersachs Journal: Basic Res Cardiol Date: 2009-06-23 Impact factor: 17.165